American Century Companies Inc. Reduces Stake in Teleflex Incorporated $TFX

American Century Companies Inc. decreased its position in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 92.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 10,280 shares of the medical technology company's stock after selling 126,675 shares during the quarter. American Century Companies Inc.'s holdings in Teleflex were worth $1,421,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of TFX. Dimensional Fund Advisors LP increased its holdings in shares of Teleflex by 69.5% during the first quarter. Dimensional Fund Advisors LP now owns 867,864 shares of the medical technology company's stock valued at $119,927,000 after acquiring an additional 355,720 shares in the last quarter. Diamond Hill Capital Management Inc. increased its holdings in shares of Teleflex by 122.8% during the first quarter. Diamond Hill Capital Management Inc. now owns 584,586 shares of the medical technology company's stock valued at $80,784,000 after acquiring an additional 322,222 shares in the last quarter. Principal Financial Group Inc. increased its holdings in shares of Teleflex by 229.9% during the first quarter. Principal Financial Group Inc. now owns 230,522 shares of the medical technology company's stock valued at $31,856,000 after acquiring an additional 160,646 shares in the last quarter. Deutsche Bank AG increased its holdings in shares of Teleflex by 62.5% during the fourth quarter. Deutsche Bank AG now owns 407,129 shares of the medical technology company's stock valued at $72,461,000 after acquiring an additional 156,524 shares in the last quarter. Finally, Public Sector Pension Investment Board increased its holdings in shares of Teleflex by 2,440.9% during the first quarter. Public Sector Pension Investment Board now owns 147,298 shares of the medical technology company's stock valued at $20,355,000 after acquiring an additional 141,501 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. Wells Fargo & Company decreased their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. Mizuho lifted their target price on Teleflex from $130.00 to $135.00 and gave the company a "neutral" rating in a research report on Friday, August 1st. Wall Street Zen raised Teleflex from a "buy" rating to a "strong-buy" rating in a research report on Sunday. Finally, Royal Bank Of Canada lifted their target price on Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a research report on Friday, August 1st. One analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Teleflex has an average rating of "Hold" and a consensus target price of $141.57.

Teleflex Stock Performance

Shares of TFX stock traded up $1.53 on Friday, hitting $130.62. 624,076 shares of the stock were exchanged, compared to its average volume of 540,424. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $5.77 billion, a PE ratio of 30.73, a P/E/G ratio of 1.82 and a beta of 1.08. Teleflex Incorporated has a one year low of $108.90 and a one year high of $249.90. The firm's 50 day moving average is $119.91 and its two-hundred day moving average is $127.67.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share for the quarter, topping the consensus estimate of $3.36 by $0.37. The company had revenue of $780.90 million during the quarter, compared to the consensus estimate of $771.53 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The firm's quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.42 EPS. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. Sell-side analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, September 15th. Stockholders of record on Friday, August 15th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, August 15th. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. Teleflex's dividend payout ratio is presently 32.00%.

Insider Activity at Teleflex

In other news, CEO Liam Kelly purchased 1,500 shares of the business's stock in a transaction dated Tuesday, August 5th. The stock was bought at an average price of $115.07 per share, for a total transaction of $172,605.00. Following the purchase, the chief executive officer owned 45,267 shares of the company's stock, valued at $5,208,873.69. The trade was a 3.43% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Gretchen R. Haggerty acquired 500 shares of the company's stock in a transaction that occurred on Wednesday, August 6th. The shares were bought at an average cost of $114.75 per share, for a total transaction of $57,375.00. Following the acquisition, the director directly owned 6,305 shares in the company, valued at $723,498.75. This represents a 8.61% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 5,500 shares of company stock worth $633,590 in the last three months. Corporate insiders own 1.40% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.